Perioperative pembrolizumab fails to significantly improve event-free survival in muscle-invasive bladder cancer
Perioperative pembrolizumab fails to significantly improve event-free survival in muscle-invasive bladder cancer
Sacituzumab govitecan combination shows promising activity in first line metastatic urothelial cancer
UEG 2026: Improving early detection of colorectal cancer
Tarlatamab's role in SCLC
WCLC 2026: Lung cancer research highlights
Safeguarding the right to work for people with advanced breast cancer (ABC) and their caregivers: A global snapshot of legislati
Equitable precision oncology in Africa
Harnessing AI and data to predict, personalise and transform cancer care
Izalontamab brenitecan shows promising activity in previously treated EGFR mutated NSCLC
Sequencing breast cancer scale-up in LMICs: Using service assessment to shape national priorities in Ethiopia
Choice of wording may influence global acceptance of adapted childhood cancer treatment guidelines
Multilevel factors shaping blinatumomab delivery across diverse LMICs